Expression of fibroblast growth factor receptor like 1 protein in oral squamous cell carcinoma and its influence on tumor cell proliferation and migration

doi:10.7518/hxkq.2020.05.015

Abstract

Abstract:

Objective This study aims to investigate the expression of fibroblast growth factor receptor like 1 (FGFRL1) in oral squamous cell carcinoma (OSCC) and reveals its association with tumor cell proliferation and migration. Methods Western blot was performed to detect the expression of FGFRL1 protein in OSCC tissues, adjacent normal tissues, OSCC cell lines and normal epithelial cells. After knocking down of FGFRL1 in HN4 cells, CCK-8 and Ki67 assays were performed to detect cell proliferation, wounding healing assay and transwell were performed to detect cell-migration. Western blot was used to detect the expression of protein related to epithelial-mesenchymal transition (EMT). Results The expression of FGFRL1 in OSCC tissues was higher than that in adjacent nontumor tissues, respectively (t=2.820, P=0.047 8). Moreover, the expression of FGFRL1 in OSCC cells was higher than that in HOK cells. Quantitative real-time polymerase chain reaction (qRT-PCR) showed that FGFRL1 expression of FGFRL1 RNA in HOK cells was lower than that in OSCC cells. HN4 cells transfected with FGFRL1 siRNA were included in the experimental group, whereas HN4 cells treated with NC siRNA were included in the control group. CCK-8 experiment showed no significant difference between the experimental and control groups with regard to proliferation ability at 48 h (P=0.478 1) and 72 h (P=0.334 2). Migration experiment showed that the wound healing areas in the experimental group after 12 h (P=0.022 8), 24 h (P=0.005 1), and 36 h (P=0.009 5）were smaller than that in the control group. Transwell invasion assay showed that the number of invaded cells in the experimental group after 16 h (P=0.008 7) and 24 h (P=0.008 6) were lower than that in the control group. Knocking-down FGFRL1 up-regulated the expression of E-cadherin and down-regulated the expression of N-cadherin and Vimentin in HN4 cells. Conclusion FGFRL1 expression in the OSCC tissues was significantly higher than that in the adjacent nontumor tissues. FGFRL1 expression in the OSCC cells was significantly higher than that in the HOK cells, and FGFRL1 had no effect on cell proliferation but promoted tumor cell migration and EMT.

Key words: fibroblast growth factor receptor like 1, oral squamous cell carcinoma, cell migration, epithelial-mesenchymal transition, RNA interference

CLC Number:

R739.8

Zheng Chen, Shi Chaoji, Du Linjuan, Jiang Yinhua, Su Jimei. Expression of fibroblast growth factor receptor like 1 protein in oral squamous cell carcinoma and its influence on tumor cell proliferation and migration[J]. West China Journal of Stomatology, 2020, 38(5): 558-565.

Figures/Tables 7

Fig 1

Fig 2

Fig 3

Fig 4

Fig 5

Fig 6

Fig 7

References 29

[1]	Hunter KD, Parkinson EK, Harrison PR . Profiling early head and neck cancer[J]. Nat Rev Cancer, 2005,5(2):127-135. doi: 10.1038/nrc1549 URL pmid: 15685196
[2]	Forastiere A, Koch W, Trotti A , et al. Head and neck cancer[J]. N Engl J Med, 2001,26(345):1890-1900.
[3]	Dienstmann R, Rodon J, Prat A , et al. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors[J]. Ann Oncol, 2014,25(3):552-563. doi: 10.1093/annonc/mdt419 URL pmid: 24265351
[4]	Beenken A, Mohammadi M . The FGF family: biology, pathophysiology and therapy[J]. Nat Rev Drug Discov, 2009,8(3):235-253. doi: 10.1038/nrd2792 URL pmid: 19247306
[5]	Trueb B . Biology of FGFRL1, the fifth fibroblast growth factor receptor[J]. Cell Mol Life Sci, 2011,68(6):951-964. doi: 10.1007/s00018-010-0576-3 URL
[6]	Sleeman M, Fraser J, McDonald M, et al. Identification of a new fibroblast growth factor receptor, FGFR5[J]. Gene, 2001,271(2):171-182. doi: 10.1016/s0378-1119(01)00518-2 URL pmid: 11418238
[7]	Trueb B, Neuhauss SC, Baertschi S , et al. Fish possess multiple copies of fgfrl1, the gene for a novel FGF receptor[J]. Biochim Biophys Acta, 2005,1727(1):65-74. doi: 10.1016/j.bbaexp.2004.12.001 URL pmid: 15652159
[8]	Ibrahimi OA, Yeh BK, Eliseenkova AV , et al. Analysis of mutations in fibroblast growth factor(FGF) and a pathogenic mutation in FGF receptor(FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization[J]. Mol Cell Biol, 2005,25(2):671-684. doi: 10.1128/MCB.25.2.671-684.2005 URL pmid: 15632068
[9]	Stauber DJ , DiGabriele AD, Hendrickson WA. Structural interactions of fibroblast growth factor receptor with its ligands[J]. Proc Natl Acad Sci U S A, 2000,97(1):49-54. doi: 10.1073/pnas.97.1.49 URL pmid: 10618369
[10]	Zuo J, Wen M, Lei M , et al. MiR-210 links hypoxia with cell proliferation regulation in human Laryngocarcinoma cancer[J]. J Cell Biochem, 2015,116(6):1039-1049. doi: 10.1002/jcb.25059 URL pmid: 25639884
[11]	Tsuchiya S . The role of microRNA-210 in esophageal squamous cell carcinoma[J]. Yakugaku Zasshi, 2012,132(9):1069-1073.
[12]	Takei Y, Matsumura T, Watanabe K , et al. FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas[J]. Oncol Lett, 2018,16(1):809-814. doi: 10.3892/ol.2018.8739 URL pmid: 29963148
[13]	Schild C, Trueb B . Aberrant expression of FGFRL1, a novel FGF receptor, in ovarian tumors[J]. Int J Mol Med, 2005,16(6):1169-1173. URL pmid: 16273302
[14]	Gerber SD, Steinber F, Beyeler M , et al. The murine Fgfrl1 receptor is essential for the development of the metanephric kidney[J]. Dev Biol, 2009,335(1):106-119. doi: 10.1016/j.ydbio.2009.08.019 URL pmid: 19715689
[15]	Steinber F, Gerber SD, Rieckmann T , et al. Rapid fusion and syncytium formation of heterologous cell upon expression of the FGFRL1 receptor[J]. J Biol Chem, 2010,285(48):37704-37715. doi: 10.1074/jbc.M110.140517 URL pmid: 20851884
[16]	Kim I, Moon S, Yu K , et al. A novel fibroblast growth factor receptor 5 preferentially expressed in the pancreas[J]. Biochim Biophys Acta, 2001,1518(1/2):152-156.
[17]	Trueb B, Taeschler S . Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development[J]. Int J Mol Med, 2006,17(4):617-620. URL pmid: 16525717
[18]	Chen R, Li D, Zheng M , et al. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1[J]. J Cell Mol Med, 2020,24(3):2123-2134. doi: 10.1111/jcmm.14763 URL pmid: 31957179
[19]	Tsuchiya S, Fujiwara T, Sato F , et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)[J]. J Biol Chem, 2011,286(1):420-428. doi: 10.1074/jbc.M110.170852 URL pmid: 21044961
[20]	Trueb B, Zhuang L, Taeschler S , et al. Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor preferentially expressed in skeletal tissues[J]. J Biol Chem, 2003,278(36):33857-33865. doi: 10.1074/jbc.M300281200 URL pmid: 12813049
[21]	Zhuang L, Steinberg F, Trueb B . Receptor FGFRL1 acts as a tumor suppressor in nude mice when overexpressed in HEK 293 Tet-On cells[J]. Oncol Lett, 2016,12(6):4524-4530. doi: 10.3892/ol.2016.5245 URL pmid: 28101211
[22]	Shimada Y, Okumura T, Nagata T , et al. Expression esophageal squamous cell carcinoma[J]. Esophagus, 2014,11:48-53. doi: 10.1007/s10388-013-0394-4 URL
[23]	Xu Q, Sun Q, Zhang J , et al. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer[J]. Carcinogenesis, 2013,34(3):539-549. doi: 10.1093/carcin/bgs374 URL
[24]	Li J, Zhou BP . Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters[J]. BMC Cancer, 2011,11:49. doi: 10.1186/1471-2407-11-49 URL pmid: 21284870
[25]	Mendelsohn AH, Lai CK, Shintaku IP , et al. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma[J]. Am J Otolaryngol, 2012,33(1):6-13. doi: 10.1016/j.amjoto.2010.11.018 URL pmid: 21439681
[26]	Liu CY, Lin HH, Tang MJ , et al. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation[J]. Oncotarget, 2015,6(18):15966-15983. doi: 10.18632/oncotarget.3862 URL pmid: 25965826
[27]	Berx G, Raspe E, Christofori G , et al. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer[J]. Clin Exp Metastasis, 2007,24(8):587-597. doi: 10.1007/s10585-007-9114-6 URL pmid: 17978854
[28]	Thiery JP, Acloque H, Huang RY , et al. Epithelial-mesenchymal transitions in development and disease[J]. Cell, 2009,139(5):871-890. doi: 10.1016/j.cell.2009.11.007 URL pmid: 19945376
[29]	Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014,15(3):178-196. doi: 10.1038/nrm3758 URL pmid: 24556840